Literature DB >> 30414319

Regulation of Tip60-dependent p53 acetylation in cell fate decision.

Ping Wang1, Han Bao2, Xiao-Peng Zhang2, Feng Liu1, Wei Wang1.   

Abstract

The acetylation of p53 plays an essential role in regulating its transcriptional activity. Nevertheless, how p53 acetylation is modulated in cell fate decision is less understood. We developed a network model to reveal how Tip60-dependent p53 acetylation is regulated to modulate cellular outcome. We proposed that p53 is progressively activated and exhibits distinct dynamics depending on the severity of DNA damage. For mild damage, p53 is primarily activated to trigger cell cycle arrest by transactivating p21, with its concentration showing pulses. For severe damage, p53 is acetylated at Lysine 120 (K120) by Tip60 to trigger apoptosis by inducing PUMA, and its concentration increases to high levels. Several p53-centered feedback loops coordinate to regulate its acetylation status, ensuring a robust decision on cell fate.
© 2018 Federation of European Biochemical Societies.

Entities:  

Keywords:  Tip60; cell fate decision; network model; numerical simulation; p53 acetylation

Mesh:

Substances:

Year:  2018        PMID: 30414319     DOI: 10.1002/1873-3468.13287

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  2 in total

1.  TIP60/P400/H4K12ac Plays a Role as a Heterochromatin Back-up Skeleton in Breast Cancer.

Authors:  Mouhamed Idrissou; Tiphanie Boisnier; Anna Sanchez; Fatma Zohra Houfaf Khoufaf; Frederique Penault-Llorca; Yves-Jean Bignon; Dominique Bernard-Gallon
Journal:  Cancer Genomics Proteomics       Date:  2020 Nov-Dec       Impact factor: 4.069

2.  Activation of Galanin Receptor 1 with M617 Attenuates Neuronal Apoptosis via ERK/GSK-3β/TIP60 Pathway After Subarachnoid Hemorrhage in Rats.

Authors:  Hui Shi; Yuanjian Fang; Lei Huang; Ling Gao; Cameron Lenahan; Takeshi Okada; Zachary D Travis; Shucai Xie; Hong Tang; Qin Lu; Rui Liu; Jiping Tang; Yuan Cheng; John H Zhang
Journal:  Neurotherapeutics       Date:  2021-06-04       Impact factor: 6.088

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.